Combination of photodynamic therapy and anti-VEGF agents in the treatment of unwanted choroidal neovasculature

Details for Australian Patent Application No. 2009327266 (hide)

Owner QLT Inc.

Inventors Strong, H. Andrew; Hao, Yong

Agent Griffith Hack

Pub. Number AU-A-2009327266

PCT Pub. Number WO2010/069073

Priority 61/182,943 01.06.09 US; 61/138,059 16.12.08 US

Filing date 16 December 2009

Wipo publication date 24 June 2010

International Classifications

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61K 31/409 (2006.01) - having four such rings, e.g. porphine derivatives, bilirubin, biliverdine

A61K 31/573 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 27/00 (2006.01) Drugs for disorders of the senses

Event Publications

14 July 2011 PCT application entered the National Phase

  PCT publication WO2010/069073 Priority application(s): WO2010/069073

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009327267-Membrane type-1 matrix metalloprotein inhibitors and uses thereof

2009327261-Production of synthesis gas through controlled oxidation of biomass